Novavax, Inc. (NVAX) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
Portfolio Pulse from
Levi & Korsinsky is investigating Novavax, Inc. for potential violations of federal securities laws following the FDA's clinical hold on its combination influenza and Covid-19 shot and stand-alone influenza vaccine.
November 15, 2024 | 12:15 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Novavax is under investigation by Levi & Korsinsky for potential securities law violations after the FDA placed a clinical hold on its vaccine developments.
The investigation by Levi & Korsinsky into potential securities law violations, combined with the FDA's clinical hold on Novavax's vaccine developments, is likely to negatively impact investor confidence and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100